| Ident. | Authors (with country if any) | Title |
|---|
| 000493 (2020) |
Justin T. Denholm [Australie] ; Joshua Davis [Australie] ; David Paterson [Australie] ; Jason Roberts [Australie, France] ; Susan Morpeth [Nouvelle-Zélande] ; Thomas Snelling [Australie] ; Dominica Zentner [Australie] ; Megan Rees [Australie] ; Matthew O'Sullivan [Australie] ; David Price [Australie] ; Asha Bowen [Australie] ; Steven Y C. Tong [Australie] | The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. |
| 000803 (2020) |
Minh Patrick Lê [France] ; Nathan Peiffer-Smadja [France] ; Jeremie Guedj [France] ; Nadège Néant [France] ; France Mentré [France] ; Florence Ader [France] ; Yazdan Yazdanpanah [France] ; Gilles Peytavin [France] | Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. |
| 000848 (2020) |
Florence Ader [France] | Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults. |
| 000B16 (2020) |
Jie Li [États-Unis] ; Ivan Pavlov [Canada] ; John G. Laffey [Irlande (pays)] ; Oriol Roca [Espagne] ; Sara Mirza [États-Unis] ; Yonatan Perez [France] ; Bairbre Mcnicholas [Irlande (pays)] ; David Cosgrave [Irlande (pays)] ; David Vines [États-Unis] ; Elsa Tavernier [France] ; Stephan Ehrmann [France] | Meta-trial of awake prone positioning with nasal high flow therapy: Invitation to join a pandemic collaborative research effort. |
| 000D97 (2020) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Johan Courjon [France] ; Valérie Giordanengo [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Dupont [France] ; Stéphane Honoré [France] ; Philippe Colson [France] ; Eric Chabrière [France] ; Bernard La Scola [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France] | Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. |
| 001059 (2020) |
Mary Daval [France] ; Alain Corré [France] ; Clement Palpacuer [France] ; Juliette Housset [France] ; Guillaume Poillon [France] ; Michael Eliezer [France] ; Benjamin Verillaud [France] ; Dorsaf Slama [France] ; Denis Ayache [France] ; Philippe Herman [France] ; Clement Jourdaine [France] ; Camille Hervé [France] ; Wissame El Bakkouri [France] ; Dominique Salmon [France] ; Charlotte Hautefort [France] | Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial. |
| 001064 (2020) |
J P Desilles [France, États-Unis] ; C. Gregoire [France] ; C. Le Cossec [France] ; J. Lambert [France] ; O. Mophawe [France] ; M R Losser [France] ; F. Lambiotte [France] ; S. Le Tacon [France] ; M. Cantier [France] ; N. Engrand [France] ; P. Trouiller [France] ; J. Pottecher [France] | Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial. |
| 001074 (2020) |
Christoph D. Spinner [Allemagne] ; Robert L. Gottlieb [États-Unis] ; Gerard J. Criner [États-Unis] ; José Ram N Arribas L Pez [Espagne] ; Anna Maria Cattelan [Italie] ; Alex Soriano Viladomiu [Espagne] ; Onyema Ogbuagu [États-Unis] ; Prashant Malhotra [États-Unis] ; Kathleen M. Mullane [États-Unis] ; Antonella Castagna [Italie] ; Louis Yi Ann Chai [Singapour] ; Meta Roestenberg [Pays-Bas] ; Owen Tak Yin Tsang [République populaire de Chine] ; Enos Bernasconi [Suisse] ; Paul Le Turnier [France] ; Shan-Chwen Chang [Taïwan] ; Devi Sengupta [États-Unis] ; Robert H. Hyland [États-Unis] ; Anu O. Osinusi [États-Unis] ; Huyen Cao [États-Unis] ; Christiana Blair [États-Unis] ; Hongyuan Wang [États-Unis] ; Anuj Gaggar [États-Unis] ; Diana M. Brainard [États-Unis] ; Mark J. Mcphail [Royaume-Uni] ; Sanjay Bhagani [Royaume-Uni] ; Mi Young Ahn [Corée du Sud] ; Arun J. Sanyal ; Gregory Huhn [États-Unis] ; Francisco M. Marty [États-Unis] | Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. |
| 001075 (2020) |
Derek C. Angus [États-Unis] ; Lennie Derde [Pays-Bas] ; Farah Al-Beidh [Royaume-Uni] ; Djillali Annane [France] ; Yaseen Arabi [Arabie saoudite] ; Abigail Beane [Royaume-Uni] ; Wilma Van Bentum-Puijk [Pays-Bas] ; Lindsay Berry [États-Unis] ; Zahra Bhimani [Canada] ; Marc Bonten [Pays-Bas] ; Charlotte Bradbury [Royaume-Uni] ; Frank Brunkhorst [Allemagne] ; Meredith Buxton [États-Unis] ; Adrian Buzgau [Australie] ; Allen C. Cheng [Australie] ; Menno De Jong [Pays-Bas] ; Michelle Detry [États-Unis] ; Lise Estcourt [Royaume-Uni] ; Mark Fitzgerald [États-Unis] ; Herman Goossens [Belgique] ; Cameron Green [Australie] ; Rashan Haniffa [Sri Lanka, Thaïlande] ; Alisa M. Higgins [Australie] ; Christopher Horvat [États-Unis] ; Sebastiaan J. Hullegie [Pays-Bas] ; Peter Kruger [Australie] ; Francois Lamontagne [Canada] ; Patrick R. Lawler [Canada] ; Kelsey Linstrum [États-Unis] ; Edward Litton [Australie] ; Elizabeth Lorenzi [États-Unis] ; John Marshall [Canada] ; Daniel Mcauley [Royaume-Uni] ; Anna Mcglothin [États-Unis] ; Shay Mcguinness [Australie, Nouvelle-Zélande] ; Bryan Mcverry [États-Unis] ; Stephanie Montgomery [États-Unis] ; Paul Mouncey [Royaume-Uni] ; Srinivas Murthy [Canada] ; Alistair Nichol [Australie, Irlande (pays)] ; Rachael Parke [Nouvelle-Zélande] ; Jane Parker [Australie] ; Kathryn Rowan [Royaume-Uni] ; Ashish Sanil [États-Unis] ; Marlene Santos [Canada] ; Christina Saunders [États-Unis] ; Christopher Seymour [États-Unis] ; Anne Turner [Nouvelle-Zélande] ; Frank Van De Veerdonk [Pays-Bas] ; Balasubramanian Venkatesh [Australie] ; Ryan Zarychanski [Canada] ; Scott Berry [États-Unis] ; Roger J. Lewis [États-Unis] ; Colin Mcarthur [Royaume-Uni, Nouvelle-Zélande] ; Steven A. Webb [Australie] ; Anthony C. Gordon [Royaume-Uni] | Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. |
| 001076 (2020) |
Pierre-François Dequin [France] ; Nicholas Heming [France] ; Ferhat Meziani [France] ; Gaëtan Plantefève [France] ; Guillaume Voiriot [France] ; Julio Badié [France] ; Bruno François [France] ; Cécile Aubron [France] ; Jean-Damien Ricard [France] ; Stephan Ehrmann [France] ; Youenn Jouan [France] ; Antoine Guillon [France] ; Marie Leclerc [France] ; Carine Coffre [France] ; Hélène Bourgoin [France] ; Céline Lengellé [France] ; Caroline Caille-Fénérol [France] ; Elsa Tavernier [France] ; Sarah Zohar [France] ; Bruno Giraudeau [France] ; Djillali Annane [France] ; Amélie Le Gouge [France] | Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial. |
| 001298 (2020) |
Mondher Toumi [France] ; Samuel Aballea [France] | Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al. |
| 001299 (2020) |
Bruno Mégarbane [France] ; Jean-Michel Scherrmann [France] | Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. |
| 001537 (2020) |
Rafael Dal-Ré [Espagne] ; Raphaël Porcher [France] ; Christian Gluud [Danemark] | COVID-19 clinical trials: ethical and scientific consequences of the RECOVERY trial results. |
| 001720 (2020) |
Katheron Intson [Canada] ; Sachin Kumar [Canada] ; Amy Botta [Canada] ; Rachael Neckles [États-Unis] ; Connie Leung [Canada] ; Ali Jawaid [Pologne] | An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19. |
| 001805 (2020) |
Alain Vandormael [Allemagne, Afrique du Sud] ; Maya Adam [États-Unis] ; Merlin Greuel [Allemagne] ; Till B Rnighausen [Allemagne, États-Unis, Afrique du Sud] | A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial. |
| 001854 (2020) |
Keisha Smith [États-Unis] ; Amy Pace [États-Unis] ; Stephan Ortiz [États-Unis] ; Shamsah Kazani [États-Unis] ; Scott Rottinghaus [États-Unis] | A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. |
